Related Experiment Video
Updated: Jun 6, 2026

The ITS2 Database
Published on: March 12, 2012
The Ids have it
Lincoln A Edwards1, Howard A Fine
1Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
In this issue of Cancer Cell, Anido et al. demonstrate that Id1 is the likely arbiter of divergent transforming growth factor-β (TGF-β) signaling in glioma-initiating cells (GICs) from different tumors. These findings hold both the promise and potential peril of therapeutic targeting of the TGF-β pathway.
Insights
Id1 protein regulates distinct transforming growth factor-beta (TGF-β) signaling pathways in glioma-initiating cells (GICs). This discovery offers insights into potential TGF-β pathway therapies for brain tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Glioma-initiating cells (GICs) exhibit diverse cellular behaviors influenced by transforming growth factor-beta (TGF-β) signaling.
- Understanding the molecular mechanisms that dictate differential TGF-β responses in GICs is crucial for effective brain tumor treatment.
Discussion:
- Anido et al. identify Inhibitor of differentiation 1 (Id1) as a key regulator mediating divergent TGF-β signaling pathways in GICs.
- The study highlights Id1's role in controlling the distinct cellular responses observed in GICs derived from various glioma tumors.
Key Insights:
- Id1 acts as a critical molecular switch, determining the specific TGF-β signaling outcome in different GICs.
- This finding elucidates a central mechanism underlying the heterogeneity of GIC behavior.
Outlook:
- Targeting the TGF-β pathway, modulated by Id1, presents a potential therapeutic strategy for gliomas.
- Further research is needed to explore the dual potential and risks associated with targeting this pathway in brain cancer therapy.
More Related Videos
12:52Iridium(III) Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II
Published on: July 7, 2015
08:37Use of the Pyrimidine Analog, 5-Iodo-2′-Deoxyuridine (IdU) with Cell Cycle Markers to Establish Cell Cycle Phases in a Mass Cytometry Platform
Published on: October 22, 2021
Related Concept Videos
Dissociative Identity Disorder
Automated Microbial Diagnostics
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Sex-linked Disorders
Sex Linked Disorders
iChip